<sentence id="0">Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion .</sentence>
<sentence id="1">We showed previously that HL-60 and F9 mouse embryonal carcinoma cells will take up and deblock peracetylated Galbeta1-4GlcNAcbeta-O-naphthalenemethanol ( Galbeta1-4GlcNAc-NM ) and use the disaccharide as a primer of oligosaccharide chains ( Sarkar , A. K. , Fritz , T. A. , Taylor , W. H. , and Esko , J. D. ( 1995 ) Proc. Natl. Acad. Sci. U. S. A. 92 , 3323-3327 ) .</sentence>
<sentence id="2">We now report that another disaccharide , acetylated GlcNAcbeta1-3Gal-naphthalenemethanol ( GlcNAcbeta1-3Gal-NM ) , has even greater potency and that both compounds will inhibit sialyl LewisX (sLex)-dependent cell adhesion .</sentence>
<sentence id="3">When fed to U937 cells , acetylated forms of Galbeta1-4GlcNAc-NM and GlcNAcbeta1-3Gal-NM primed oligosaccharides in a dose-dependent manner .</sentence>
<sentence id="4">Analysis of compounds assembled on Galbeta1-4GlcNAc-NM showed only one product , namely Galbeta1-4(Fucalpha1-3)GlcNAc-NM .</sentence>
<sentence id="5">In contrast , GlcNAcbeta1-3Gal-NM generated Galbeta1-4GlcNAcbeta1-3Gal-NM , Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Gal-NM , NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Gal-NM , and NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1- 3Gal-NM .</sentence>
<sentence id="6">Both compounds decreased the incorporation of [3H]fucose into cellular glycoconjugates , <scope type="neg" id="0"><cue type="neg" id="0">without</cue> affecting the incorporation of [3H]mannosamine , a precursor of sialic acid residues</scope> .</sentence>
<sentence id="7">Moreover , <scope type="neg" id="1">the overall extent of sialylation was <cue type="neg" id="1">not</cue> affected based on the reactivity of cells to fluorescein isothiocyanate-conjugated Maackia amurensis lectin</scope> .</sentence>
<sentence id="8">Priming inhibited expression of sLex on cell surface glycoconjugates , which reduced E-selectin-dependent cell adhesion to tumor necrosis factor-alpha-activated human umbilical vein endothelial cells .</sentence>
<sentence id="9">GlcNAcbeta1-3Gal-NM and Galbeta1-4GlcNAc-NM represent starting points for making enzyme-specific , site-directed inhibitors of glycosyltransferases that <scope type="spec" id="2"> <cue type="spec" id="2">could</cue> act in living cells</scope> .</sentence>